XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 8,238 $ 12,126
Accounts receivable 0 173
G42 Promissory Note receivable 0 12,243
Prepaid expenses and other current assets 1,872 2,537
Current deposits 15 15
Total current assets 10,125 27,094
Property and equipment, net 140 207
Operating lease right-of-use assets 272 349
Long-term investments 4,387 5,588
Total assets 14,924 33,238
Current liabilities:    
Accounts payable and accrued expenses 9,620 7,313
Current portion of operating lease liabilities 165 154
Current portion of contract liabilities 17 17
Current portion of notes payable 473 224
Total current liabilities 10,275 7,708
Contract liabilities, net of current portion 18,669 18,669
Operating lease liabilities, net of current portion 213 338
Warrant liability, related party 278 684
Total liabilities 29,435 27,399
Commitments and contingencies
Redeemable noncontrolling interest 10,722 16,579
Stockholders’ deficit:    
Additional paid-in capital 254,912 253,737
Accumulated deficit (281,192) (265,524)
Total stockholders’ deficit attributable to vTv Therapeutics Inc. (25,233) (10,740)
Total liabilities, redeemable noncontrolling interest and stockholders’ deficit 14,924 33,238
Class A Common Stock    
Stockholders’ deficit:    
Common stock value 815 815
Class B Common Stock    
Stockholders’ deficit:    
Common stock value $ 232 $ 232